Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Aug 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2379501000001111 | Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials 10 dose | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2379521000001116 | Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials 10 dose (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials 10 dose | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials 10 dose | Has VMP | Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials 10 dose | VMP prescribing status (attribute) | Never valid to prescribe as a VMP | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials 10 dose | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials 10 dose | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials 10 dose | Has dispensed dose form | Conventional release emulsion for injection | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials (Sanofi Pasteur) 10 dose | Is a | True | Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials 10 dose | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR